Suggested Topics within your search.
Suggested Topics within your search.
- Biochemistry 3
- Cancer 3
- Chemistry, Clinical 2
- Health and Fitness 2
- medicine 2
- methods 2
- Biochemical Phenomena 1
- Breast 1
- Clinical biochemistry 1
- Diagnosis, Differential 1
- Genetic Phenomena 1
- Genetic Structures 1
- Genetic Techniques 1
- Genetics 1
- Genital Diseases, Female 1
- Genomics 1
- Gynecology 1
- Health and Wellbeing 1
- Immunological aspects 1
- Labor, Obstetric 1
- Molecular Biology 1
- Moral and ethical aspects 1
- Nurse and patient 1
- Nursing 1
- Obstetrics 1
- Oncology 1
- Pediatrics 1
- Physical therapy 1
- Practice 1
- Pregnancy 1
-
801
Serum PM20D1 levels are associated with nutritional status and inflammatory factors in gastric cancer patients undergoing early enteral nutrition
Published 2025-02-01Subjects: Get full text
Article -
802
JAK/STAT3 signaling promotes pain and depression-like behaviors in rats with bone cancer pain by regulating Th17 cell differentiation
Published 2025-02-01Subjects: “…Bone cancer pain…”
Get full text
Article -
803
-
804
Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer
Published 2025-02-01Subjects: “…lung cancer…”
Get full text
Article -
805
Effect of trilaciclib administered before chemotherapy in patients with extensive-stage small-cell lung cancer: A pooled analysis of four randomized studies
Published 2024-01-01Subjects: “…Extensive-stage small-cell lung cancer…”
Get full text
Article -
806
-
807
Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study
Published 2019-03-01“…Interventions Targeted therapies have been proven to provide clinical benefits to patients with metastatic non-small cell lung cancer (NSCLC). Gefitinib was initially approved and reimbursed as a third-line therapy for patients with advanced NSCLC by the Taiwan National Health Insurance (NHI) in 2004; subsequently it became a second-line therapy (in 2007) and further a first-line therapy (in 2011) for patients with epidermal growth factor receptor mutation-positive advanced NSCLC. …”
Get full text
Article -
808
-
809
Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
Published 2025-02-01“…Journal of Experimental & Clinical Cancer Research…”
Get full text
Article -
810
-
811
A comprehensive analysis and comparative study of the trends in thyroid cancer burden in China and globally from 1990 to 2021, with projections for the next 15 Years
Published 2025-02-01Subjects: “…thyroid cancer…”
Get full text
Article -
812
Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
813
-
814
Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)
Published 2018-08-01“…To compare results of radical surgery in IBD-associated colorectal cancer (IBD-CRC) and sporadic colorectal cancer (spCRC) patients. …”
Get full text
Article -
815
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
Published 2025-01-01Subjects: “…Advanced non-small cell lung cancer…”
Get full text
Article -
816
Squamous cell carcinoma of the bronchus associated with human papillomavirus infection
Published 2025-01-01Subjects: “…Bronchial cancer…”
Get full text
Article -
817
Clinical treatment score Post-5 Years (CTS5) predicts the benefit of postmastectomy radiotherapy in patients with T1-2N1 luminal breast cancer
Published 2025-02-01Subjects: “…Breast cancer…”
Get full text
Article -
818
Cytotoxicity and Exposure Assessment of PM2.5 in a Residential Home during COVID-19 Lockdown
Published 2024-03-01Subjects: Get full text
Article -
819
-
820
Improving CD3 bispecific antibody therapy in solid tumors using combination strategies
Published 2025-02-01Subjects: Get full text
Article